Hypertensive disorders of pregnancy: a UK-based perspective.
Chandiramani
Manju
M
King's College London, Division of Reproduction and Endocrinology, London, UK. manju.chandiramani@kcl.ac.uk
Shennan
Andrew
A
D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D015415:Biomarkers; D005260:Female; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy; D046110:Hypertension, Pregnancy-Induced / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D011225:Pre-Eclampsia / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011256:Pregnancy Outcome; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D006113:United Kingdom / Q000453:epidemiology
D000927:Anticonvulsants; D000959:Antihypertensive Agents; D015415:Biomarkers